Rilexine 75 mg, Tabletten für Hunde und Katzen
Rilexine 75 mg, Tabletten für Hunde und Katzen
Authorised
- Cefalexin monohydrate
Product identification
Medicine name:
Rilexine 75 mg, Tabletten für Hunde und Katzen
Active substance:
- Cefalexin monohydrate
Target species:
-
Cat
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Cefalexin monohydrate78.88/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01DB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Available in:
-
Germany
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 401026.00.00
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 14/03/2026
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 14/03/2026
2401026-parde-20200708.pdf
German (PDF)
Download Published on: 14/03/2026